Lilly(Eli) (LLY) P/B (1999 - 2026)
Lilly(Eli) (LLY) P/B from Nov 1, 1999 to Jul 20, 2026. The TTM Lilly(Eli) (LLY) P/B is 32.87. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Lilly(Eli) (LLY)
| Year | P/B | Change |
|---|---|---|
| 2026 | 32.87 | -9.52% |
| 2025 | 36.32 | -25.88% |
| 2024 | 49.01 | +4.85% |
| 2023 | 46.75 | +42.86% |
| 2022 | 32.72 | +17.32% |
| 2021 | 27.89 | +2.73% |
| 2020 | 27.15 | -41.07% |
| 2019 | 46.08 | +283.52% |
| 2018 | 12.01 | +101.07% |
| 2017 | 5.98 | +19.73% |
| 2016 | 4.99 | -18.69% |
| 2015 | 6.14 | +27.87% |
| 2014 | 4.80 | +53.62% |
| 2013 | 3.12 | +4.64% |
| 2012 | 2.99 | +20.95% |
| 2011 | 2.47 | -2.23% |
| 2010 | 2.53 | -24.70% |
| 2009 | 3.35 | -37.27% |
| 2008 | 5.35 | +249.25% |
| 2007 | 1.53 | +2.48% |
| 2006 | 1.49 | -7.93% |
| 2005 | 1.62 | -0.28% |
| 2004 | 1.63 | -19.31% |
| 2003 | 2.02 | +10.76% |
| 2002 | 1.82 | -19.15% |
| 2001 | 2.25 | -15.60% |
| 2000 | 2.67 | +39.94% |
| 1999 | 1.91 | N/A |
Comparison Lilly(Eli) (LLY) P/B with competitors
Lilly(Eli) (LLY) P/B is 32.87.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -97.92% |
| GRFS | Grifols SA | 0.79 | -97.60% |
| SNY | Sanofi | 1.27 | -96.14% |
| BIIB | Biogen Inc | 1.52 | -95.38% |
| PFE | Pfizer Inc | 1.55 | -95.29% |
| OGN | Organon & Company | 3.93 | -88.06% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -87.55% |
| GSK | GSK Plc | 4.37 | -86.70% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -81.62% |
| AZN | Astrazeneca plc | 6.20 | -81.14% |
| MRK | Merck & Co Inc | 6.68 | -79.68% |
| GILD | Gilead Sciences Inc | 6.94 | -78.89% |
| NVO | Novo Nordisk | 7.07 | -78.49% |
| NVS | Novartis AG | 7.60 | -76.88% |
| JNJ | Johnson & Johnson | 7.64 | -76.76% |
| NSRX | Nasus Pharma Ltd | 12.90 | -60.75% |
| MDCX | MDCorp | 15.34 | -53.33% |
| AMGN | AMGEN Inc | 21.17 | -35.59% |
| SCLX | Scilex Holding Company | 28.85 | -12.23% |
| ABBV | Abbvie Inc | 50.46 | +53.52% |